Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» A 130/30 Generic Pharma Trading Strategy
A 130/30 Generic Pharma Trading Strategy
A 130/30 Generic Pharma Trading Strategy
Submitted by
admin
on February 24, 2009 - 7:08am
Source:
Seeking Alpha
News Tags:
generics
Amgen
AstraZeneca
Bristol-Myers Squibb
Pfizer
GSK
Takeda
Sanofi
Merck
Teva Pharmaceuticals
Mylan
Taro
Impax
Dr Reddy's
Watson Pharmaceuticals
Par Pharmaceutical
Momenta
Caraco
Perrigo Company
Hi Tech Pharmacal
Headline:
A 130/30 Generic Pharma Trading Strategy
Do Not Allow Advertisers to Use My Personal information
